Search Within

Kamalika Moulick

Formats
  1. Journal Article (10)
  2. Meeting Abstract (6)
Groups
  1. GSK Faculty (15)
  2. Center for Hematologic Malignancies (14)
  3. Hematologic Malignancies Research (14)
  4. Molecular Pharmacology and Chemistry Program Faculty (14)
  5. Sloan Kettering Institute Faculty (14)
  6. Sloan Kettering Institute Postdocs (12)

More Groups

People
  1. Gabriela Chiosis (14)
  2. Anna Rodina Balingcongan (11)
  3. Julia Aguirre (7)
  4. Danuta Zatorska (6)
  5. James Ahn (6)
  6. Joungnam Kim (6)

More People

Years
  1. 2017 (1)
  2. 2015 (1)
  3. 2012 (2)
  4. 2011 (3)
  5. 2009 (1)
  6. 2007 (4)

More Years

Publications
  1. Cancer Research (4)
  2. Molecular Cancer Therapeutics (2)
  3. Nature Chemical Biology (2)
  4. Proceedings of the National Academy of Sciences of the United States of America (2)
  5. Anti-Cancer Agents in Medicinal Chemistry (1)
  6. Assay and Drug Development Technologies (1)

More Publications

Publishers
  1. American Association for Cancer Research (6)
  2. Pergamon-Elsevier Science Ltd (3)
  3. National Academy of Sciences (2)
  4. Nature Publishing Group (2)
  5. Bentham Science Publishers (1)
  6. Mary Ann Liebert, Inc (1)

More Publishers

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combined inhibition of NEDD8-activating enzyme and mTOR suppresses NF2 loss-driven tumorigenesis
    Journal Article

    Cooper, J.; Xu, Q.; Zhou, L.; Pavlovic, M.; Ojeda, V.; Moulick, K.; De Stanchina, E.; Poirier, J. T.; Zauderer, M.; Rudin, C. M.; more...
    Molecular Cancer Therapeutics (2017)

    Fulltext@MSK | Save
  • GDC-0980, a dual PI3K/mTOR inhibitor, selectively inhibits NF2 mutant malignant mesothelioma (MM) cells and inhibits TOR signaling without activating Akt or ERK
    Meeting Abstract

    Zauderer, M. G.; Moulik, K.; Cooper, J.; Krug, L. M.; Giancotti, F.
    Molecular Cancer Therapeutics (2015)

    Fulltext@MSK | Save
  • Biochemical evidence towards the existence of an oncogenic Hsp90 complex
    Meeting Abstract

    Rodina, A.; Moulick, K.; Ahn, J.; Zong, H. L.; Cerchietti, L.; DaGama, E. G.; Caldas-Lopes, E.; Beebe, K.; Perna, F.; Hatzi, K.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
    Meeting Abstract

    Gomes-DaGama, E. M.; Moulick, K.; Ahn, J. H.; Zong, H.; Rodina, A.; Cerchietti, L.; Lopes-Vazquez, M. E. C.; Beebe, K.; Perna, F.; Katerina, C.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
    Journal Article

    Moulick, K.; Ahn, J. H.; Zong, H.; Rodina, A.; Cerchietti, L.; Gomes DaGama, E. M.; Caldas-Lopes, E.; Beebe, K.; Perna, F.; Hatzi, K.; more...
    Nature Chemical Biology (2011)

    Fulltext@MSK | Save
  • Design, synthesis, and evaluation of small molecule Hsp90 probes
    Journal Article

    Taldone, T.; Zatorska, D.; Patel, P. D.; Zong, H.; Rodina, A.; Ahn, J. H.; Moulick, K.; Guzman, M. L.; Chiosis, G.
    Bioorganic & Medicinal Chemistry (2011)

    Fulltext@MSK | Save
  • Design of a flexible cell-based assay for the evaluation of heat shock protein 70 expression modulators
    Journal Article

    Ahn, J. H.; Luo, W.; Kim, J.; Rodina, A.; Clement, C. C.; Aguirre, J.; Sun, W.; Kang, Y.; Maharaj, R.; Moulick, K.; more...
    Assay and Drug Development Technologies (2011)

    Fulltext@MSK | Save
  • Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models
    Journal Article

    Caldas-Lopes, E.; Cerchietti, L.; Ahn, J. H.; Clement, C. C.; Robles, A. I.; Rodina, A.; Moulick, K.; Taldone, T.; Gozman, A.; Guo, Y.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2009)

    Fulltext@MSK | Save
  • Targeting basal-like breast cancer via purine-scaffold Hsp90 inhibitors
    Meeting Abstract

    Lopes, E. C.; Joungnam, K.; Rondina, A.; Moulick, K.; Chiosis, G.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer
    Journal Article

    Rodina, A.; Vilenchik, M.; Moulick, K.; Aguirre, J.; Kim, J.; Chiang, A.; Litz, J.; Clement, C. C.; Kang, Y.; She, Y.; more...
    Nature Chemical Biology (2007)

    Fulltext@MSK | Save